(Q81221835)

English

Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro

scientific article published on 15 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Reto Schumacher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Mario Amacker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Danielle Neuhaus

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Rachel Rosenthal

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Célia Groeper

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Michael Heberer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Giulio C Spagnoli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Rinaldo Zurbriggen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Michel Adamina

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

15 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

48-49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5572-5582

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

T-cell responses of vaccinated cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

On differences between immunity and immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Degradation of the tumor antigen epitope gp100(280-288) by fibroblast-associated enzymes abolishes specific immunorecognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

A rapid and sensitive sub-micro phosphorus determination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Quantitation of proteins by elution of Coomassie brilliant blue R from stained bands after sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

An overview of real-time quantitative PCR: applications to quantify cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

The polypeptide composition of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.099

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16165256%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81221835&oldid=1382082476"